Genzyme Osteopenia/Osteoporosis Study

Completed

• Conditions: Gaucher Disease
• Interventions: Other: Gaucher disease DNA mutation analysis

• Registration Number: NCT02785744
• Lead Sponsor: NYU Langone Health

Brief Summary

Gaucher disease is a most common genetic metabolic disease characterized by low platelet number, liver and spleen enlargement and various forms of bone diseases including low bone mineral density leading to brittle bones. Various treatment options are now available for this disease.

The purpose of this research study is to determine the prevalence of Gaucher disease in patients with low bone mineral density as observed by DEXA scan, which is a form of X-Ray of the bone.

Detailed Description

Gaucher disease is a potential secondary cause of low bone mineral density and it is prevalent among patients with low BMD. This cross sectional design study will measure point prevalence of Gaucher disease in patients with low bone mineral density (BMD).

Study Timeline

• Study Start: 2016-04-01
• Study First Submitted: 2016-05-25
• Study First Submitted QC: 2016-05-27
• Study First Posted: 2016-05-30
• Primary Completion: 2019-09-01
• Study Completion: 2019-09-01
• Status Verified: 2021-03
• Last Update Submitted: 2021-03-22
• Last Update Posted: 2021-03-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

• Patients > or equal to18 years and able to provide written consent.
• Patients who have had a bone density test demonstrating T-score <-1.0 on a DEXA scan within the past year or those who are prospectively referred for DEXA scan and who are later identified by their physician to have a DEXA T-score < -1.0.

Read More

Exclusion Criteria

• Subject unable to read and sign consent form.
• Terminally ill subjects or subjects with serious co-morbidities (malignancy), which would limit the ability of the patient to participate in the study.
• Subjects with the following disorders or exposures
• Underlying skeletal dysplasia
• An endocrinologic/metabolic disease known to cause bone demineralization: including parathyroid dysfunction, hyperthyroidism, Cushing syndrome, hypogonadism, panhypopituitarism
• Cystic Fibrosis
• Exposure to medications that are known to cause low BMD including chemotherapy within past 2 years, chronic corticosteroid or phenytoin use within past 2 years
• Radiation exposure within the past 5 years
• Vitamin D deficiency is not an exclusion criteria as this is highly prevalent in the adult population under investigation as well as in patients with Gaucher disease. (9, 10)
• Subjects previously diagnosed with Gaucher Disease

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients receiving DEXA Scan	Gaucher disease DNA mutation analysis	Gaucher patients referred for dual energy X-ray absorptiometry (DEXA scan), who were found to have T-score \<-1.0.

Primary Outcome Measures

Name	Time	Method
Population prevalence of Gaucher disease among patients with low bone mineral density	2 Years

Trial Locations

Locations (1)

New York University School of Medicine; 🇺🇸 New York, New York, United States